Читать книгу Autologous Blood Concentrates - Arun K Garg - Страница 22
Conclusion
ОглавлениеThe dental and medical community has traveled a great distance since the mid-1980s when platelets were understood essentially as cells promoting hemostasis. The discovery of growth factors released by platelets introduced regenerative medical therapies that have become the present focus of a great deal of speculation and experimentation in the medical profession.
The succeeding chapters cover both the present and future science of autologous blood concentrates by casting more light than heat on the ongoing conversations concerning standardization and replication of techniques and procedures. It is the author’s hope that these chapters will contribute valuable insights concerning biologic/regenerative therapies, helping to remove much of the skepticism regarding the applications of PRP and related autologous products used in a growing number of medical fields, but particularly the fields of oral and maxillofacial surgery, periodontics, dental implants, and facial cosmetic surgery.
References
1. Marx RE, Garg A. Dental and Craniofacial Applications of Platelet-Rich Plasma. Chicago: Quintessence, 2005.
2. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981;90:262–270.
3. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983;221:1283–1285.
4. Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 1987;64:379–390.
5. Hunt TK. The physiology of wound healing. Ann Emerg Med 1988;17:1265–1273.
6. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990;160:519–524.
7. Davis JC, Hunt TK (eds). Problem Wounds—The Role of Oxygen. New York: Elsevier, 1988.
8. Marx RE, Smith BR. An improved technique for development of the pectoralis major myocutaneous flap. J Oral Maxillofac Surg 1990;48:1168–1180.
9. Cordeiro PG, Disa JJ, Hidalgo DA, Hu QY. Reconstruction of the mandible with osseous free flaps: A 10-year experience with 150 consecutive patients. Plast Reconstr Surg 1999;104:1314–1320.
10. Crowther M, Brown NJ, Bishop ET, Lewis CE. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 2001;70:478–490.
11. Moeller BJ, Cao Y, Vujaskovic Z, Li CY, Haroon ZA, Dewhirst MW. The relationship between hypoxia and angiogenesis. Semin Radiat Oncol 2004;14:215–221.
12. Ramakrishnan VR, Yao W, Campana JP. Improved skin paddle survival in pectoralis major myocutaneous flap reconstruction of head and neck defects. Arch Facial Plast Surg 2009;11:306–310.
13. Hunter S, Langemo DK, Anderson J, Hanson D, Thompson P. Hyperbaric oxygen therapy for chronic wounds. Adv Skin Wound Care 2010;23:116–119.
14. Larsson A, Uusijärvi J, Eksborg S, Lindholm P. Tissue oxygenation measured with near infrared spectroscopy during normobaric and hyperbaric oxygen breathing in healthy subjects. Eur J Appl Physiol 2010;109:757–761.
15. Vanni CM, Pinto FR, de Matos LL, de Matos MG, Kanda JL. The subclavicular versus the supraclavicular route for pectoralis major myocutaneous flap: A cadaveric anatomic study. Eur Arch Otorhinolaryngol 2010;267:1141–1146.
16. Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Babilas P. Oxygen in acute and chronic wound healing. Br J Dermatol 2010;163:257–268.
17. Knighton DR, Hunt TK, Thakral KK, Goodson WH 3rd. Role of platelets and fibrin in the healing sequence: An in vivo study of angiogenesis and collagen synthesis. Ann Surg 1982;196:379–388.
18. Hunt TK, Knighton DR, Thakral KK, Goodson WH 3rd, Andrews WS. Studies on inflammation and wound healing: Angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery 1984;96:48–54.
19. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987;57:673–686.
20. Ofosu FA. The blood platelet as a model for regulating blood coagulation on cell surfaces and its consequences. Biochemistry (Mosc) 2002;67:47–55.
21. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci 2008;13:3532–3548.
22. Roy S, Driggs J, Elgharably H, et al. Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Wound Repair Regen 2011;19:753–766.
23. Malhotra A, Pelletier MH, Yu Y, Walsh WR. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg 2013;133:153–165.
24. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 1974;71:1207–1210.
25. Witte LD, Kaplan KL, Nossel HL, Lages BA, Weiss HJ, Goodman DS. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 1978;42:402–409.
26. Ross R, Nist C, Kariya B, Rivest MJ, Raines E, Callis J. Physiological quiescence in plasma-derived serum: Influence of platelet-derived growth factor on cell growth in culture. J Cell Physiol 1978;97(3 pt 2 suppl 1):497–508.
27. Kaplan DR, Chao FC, Stiles CD, Antoniades HN, Scher CD. Platelet alpha granules contain a growth factor for fibroblasts. Blood 1979;53:1043–1052.
28. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983;258:7155–7160.
29. Derynck R. Transforming growth factor-alpha: Structure and biological activities. J Cell Biochem 1986;32:293–304.
30. Karey KP, Marquardt H, Sirbasku DA. Human platelet-derived mitogens. I. Identification of insulinlike growth factors I and II by purification and N alpha amino acid sequence analysis. Blood 1989;74:1084–1092.
31. Karey KP, Sirbasku DA. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the alpha-granule and release in response to thrombin. Blood 1989;74:1093–1100.
32. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993;81:631–638.
33. Dooley DC, Oppenlander BK, Spurgin P, et al. Basic fibroblast growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures. J Cell Physiol 1995;165:386–397.
34. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956–964.
35. Hormbrey E, Gillespie P, Turner K, et al. A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful? Clin Exp Metastasis 2002;19:651–663.
36. Sánchez M, Anitua E, Andia I. Poor standardization in platelet-rich therapies hampers advancement. Arthroscopy 2010;26:725–726.
37. Taylor DW, Petrera M, Hendry M, Theodoropoulos JS. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med 2011;21:344–352.
38. Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev 2014;4:CD010071.
39. Kim TH, Kim SH, Sándor GK, Kim YD. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol 2014;59:550–558.
40. Sandrey MA. Autologous growth factor injections in chronic tendinopathy. J Athl Train 2014;49:428–430.
41. Stellos K, Langer H, Daub K, et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 2008;117:206–215.
42. Okabe K, Yamada Y, Ito K, Kohgo T, Yoshimi R, Ueda M. Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffolds. Cytotherapy 2009;11:307–316.
43. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: Evidence to support its use. Knee Surg Sports Traumatol Arthrosc 2011;19:516–527.
44. Wu CC, Chen WH, Zao B, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 2011;32:5847–5854.
45. Bava ED, Barber FA. Platelet-rich plasma products in sports medicine. Phys Sportsmed 2011;39:94–99.
46. Torricelli P, Fini M, Filardo G, et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 2011;35:1569–1576.
47. Smyth NA, Murawski CD, Fortier LA, Cole BJ, Kennedy JG. Platelet-rich plasma in the pathologic processes of cartilage: Review of basic science evidence. Arthroscopy 2013;29:1399–1409.
48. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638–646.
49. Ono A, Westein E, Hsiao S, et al. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood 2008;112:90–99.
50. Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res 2013;99:342–352.
51. Karpatkin S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978;51:307–316.
52. Hartley PS. Platelet senescence and death. Clin Lab 2007;53:157–166.
53. White JG. Electron microscopy methods for studying platelet structure and function. Methods Mol Biol 2004;272:47–63.
54. Coppinger JA, Maguire PB. Insights into the platelet releasate. Curr Pharm Des 2007;13:2640–2646.
55. Bijak M, Saluk J, Ponczek MB, Nowak P, Wachowicz B. The synthesis of proteins in unnucleated blood platelets [in Polish]. Postepy Hig Med Dosw (Online) 2013;67:672–679.
56. Weyrich A, Cipollone F, Mezzetti A, Zimmerman G. Platelets in atherothrombosis: New and evolving roles. Curr Pharm Des 2007;13:1685–1691.
57. Linden MD, Jackson DE. Platelets: Pleiotropic roles in atherogenesis and atherothrombosis. Int J Biochem Cell Biol 2010;42:1762–1766.
58. Schattner M. Platelets and galectins. Ann Transl Med 2014;2:85.
59. Romaniuk MA, Rabinovich GA, Schattner M. Galectins in the regulation of platelet biology. Methods Mol Biol 2015;1207:269–283.
60. Garraud O, Cognasse F. Platelet toll-like receptor expression: The link between “danger” ligands and inflammation. Inflamm Allergy Drug Targets 2010;9:322–333.
61. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105(suppl 1):S13–S33.
62. Goubau C, Buyse GM, Di Michele M, Van Geet C, Freson K. Regulated granule trafficking in platelets and neurons: A common molecular machinery. Eur J Paediatr Neurol 2013;17:117–125.
63. Habets KL, Huizinga TW, Toes RE. Platelets and autoimmunity. Eur J Clin Invest 2013;43:746–757.
64. Koseoglu S, Flaumenhaft R. Advances in platelet granule biology. Curr Opin Hematol 2013;20:464–471.
65. Golebiewska EM, Poole AW. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev 2015;29:153–162.
66. Duchene J, von Hundelshausen P. Platelet-derived chemokines in atherosclerosis. Hamostaseologie 2015;35:137–141.
67. van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA. Platelet-rich plasma: Quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 2006;12:3067–3073.
68. Nikolidakis D, Jansen JA. The biology of platelet-rich plasma and its application in oral surgery: Literature review. Tissue Eng Part B Rev 2008;14:249–258.
69. Lubkowska A, Dolegowska B, Banfi G. Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents 2012;26(2 suppl 1):3S–22S.
70. Uutela M, Wirzenius M, Paavonen K, et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 2004;104:3198–3204.
71. Everts PA, Knape JT, Weibrich G, et al. Platelet-rich plasma and platelet gel: A review. J Extra Corpor Technol 2006;38:174–187.
72. Appelmann I, Liersch R, Kessler T, Mesters RM, Berdel WE. Angiogenesis inhibition in cancer therapy: Platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors. Biological functions and role in malignancy. Recent Results Cancer Res 2010;180:51–81.
73. Caplan AI. Mesenchymal stem cells and gene therapy. Clin Orthop Relat Res 2000;(379 suppl):S67–S70.
74. Tocci A, Forte L. Mesenchymal stem cell: Use and perspectives. Hematol J 2003;4:92–96.
75. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, La Russa VF. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 2005;5:1571–1584.
76. Ye JS, Su XS, Stoltz JF, de Isla N, Zhang L. Signaling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes. Cell Prolif 2015;48:157–165.
77. Ball SG, Shuttleworth CA, Kielty CM. Mesenchymal stem cells and neovascularization: Role of platelet-derived growth factor receptors. J Cell Mol Med 2007;11:1012–1030.
78. Graham S, Leonidou A, Lester M, Heliotis M, Mantalaris A, Tsiridis E. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs 2009;18:1633–1654.
79. Hellberg C, Ostman A, Heldin CH. PDGF and vessel maturation. Recent Results Cancer Res 2010;180:103–114.
80. Javed F, Al-Askar M, Al-Rasheed A, Al-Hezaimi K. Significance of the platelet-derived growth factor in periodontal tissue regeneration. Arch Oral Biol 2011;56:1476–1484.
81. Donovan J, Abraham D, Norman J. Platelet-derived growth factor signaling in mesenchymal cells. Front Biosci (Landmark Ed) 2013;18:106–119.
82. Iwayama T, Olson LE. Involvement of PDGF in fibrosis and scleroderma: Recent insights from animal models and potential therapeutic opportunities. Curr Rheumatol Rep 2013;15:304.
83. Shah P, Keppler L, Rutkowski J. A review of platelet derived growth factor playing pivotal role in bone regeneration. J Oral Implantol 2014;40:330–340.
84. Finnson KW, McLean S, Di Guglielmo GM, Philip A. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Adv Wound Care (New Rochelle) 2013;2:195–214.
85. Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A. Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care (New Rochelle) 2013;2:215–224.
86. Ferguson MW, O’Kane S. Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004;359:839–850.
87. Bachem MG, Zhou Z, Zhou S, Siech M. Role of stellate cells in pancreatic fibrogenesis associated with acute and chronic pancreatitis. J Gastroenterol Hepatol 2006;21(suppl 3):S92–S96.
88. Occleston NL, Laverty HG, O’Kane S, Ferguson MW. Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFbeta3): From laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 2008;19:1047–1063.
89. Lo DD, Zimmermann AS, Nauta A, Longaker MT, Lorenz HP. Scarless fetal skin wound healing update. Birth Defects Res C Embryo Today 2012;96:237–247.
90. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585–601.
91. Yang B, Zhou L, Peng B, Sun Z, Dai Y, Zheng J. In vitro comparative evaluation of recombinant growth factors for tissue engineering of bladder in patients with neurogenic bladder. J Surg Res 2014;186:63–72.
92. Song F, Tang J, Geng R, et al. Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model. Int J Clin Exp Pathol 2014;7:1415–1426.
93. Mariani E, Pulsatelli L, Facchini A. Signaling pathways in cartilage repair. Int J Mol Sci 2014;15:8667–8698.
94. Mammoto T, Jiang A, Jiang E, Mammoto A. Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway. Microvasc Res 2013;89:15–24.
95. Jeong DU, Lee CR, Lee JH, et al. Clinical applications of platelet-rich plasma in patellar tendinopathy. Biomed Res Int 2014;2014:249498.
96. Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res 2005;84:1093–1103.
97. Wang Y, Nishida S, Sakata T, et al. Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology 2006;147:4753–4761.
98. Sroga GE, Wu PC, Vashishth D. Insulin-like growth factor 1, glycation and bone fragility: Implications for fracture resistance of bone. PLoS One 2015;10:e0117046.
99. Omori E, Inagaki M, Mishina Y, Matsumoto K, Ninomiya-Tsuji J. Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species. Proc Natl Acad Sci U S A 2012;109:3365–3370.
100. Stratman AN, Davis GE. Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: Influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal 2012;18:68–80.
101. Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg 2004;62:489–496.
102. Hallman M, Thor A. Bone substitutes and growth factors as an alternative/complement to autogenous bone for grafting in implant dentistry. Periodontol 2000 2008;47:172–192.
103. Akhundov K, Pietramaggiori G, Waselle L, et al. Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Disasters 2012;25:207–213.
104. Pietrzak WS, Eppley BL. Platelet rich plasma: Biology and new technology. J Craniofac Surg 2005;16:1043–1054.
105. Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: A review of biology and applications in plastic surgery. Plast Reconstr Surg 2006;118:147e–159e.
106. Rodrigues SV, Acharya AB, Thakur SL. Platelet-rich plasma. A review. N Y State Dent J 2012;78:26–30.
107. Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med 2003;33:381–394.
108. Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. J Bone Joint Surg Br 2009;91:987–996.
109. Carless PA, Rubens FD, Anthony DM, O’Connell D, Henry DA. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;(3):CD004172.
110. Vu TD, Pal SN, Ti LK, et al. An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: A translational approach: Vu and Pal “Myocardial Repair: PRP, Hydrogel and Supplements.” Biomaterials 2015;45:27–35.
111. Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol 2013;13:47.
112. Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007;35:245–251.
113. Randelli PS, Arrigoni P, Cabitza P, Volpi P, Maffulli N. Autologous platelet rich plasma for arthroscopic rotator cuff repair. A pilot study. Disabil Rehabil 2008;30:1584–1589.
114. Chahal J, Van Thiel GS, Mall N, et al. The role of platelet-rich plasma in arthroscopic rotator cuff repair: A systematic review with quantitative synthesis. Arthroscopy 2012;28:1718–1727.
115. Charousset C, Zaoui A, Bellaïche L, Piterman M. Does autologous leukocyte-platelet-rich plasma improve tendon healing in arthroscopic repair of large or massive rotator cuff tears? Arthroscopy 2014;30:428–435.
116. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003;90:133–146.
117. Kirsner RS, Warriner R, Michela M, Stasik L, Freeman K. Advanced biological therapies for diabetic foot ulcers. Arch Dermatol 2010;146:857–862.
118. Gawdat HI, Hegazy RA, Fawzy MM, Fathy M. Autologous platelet rich plasma: Topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars. Dermatol Surg 2014;40:152–161 [erratum 2014;40:601].
119. Assenza M, Valesini L, Monacelli G, et al. Traumatic complex wounds, multidisciplinary approach: Our experience in a case series. Clin Ter 2010;161:e95–e99.
120. Serra R, Buffone G, Dominijanni A, Molinari V, Montemurro R, de Franciscis S. Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients. Int Wound J 2013;10:612–615.
121. Yamada T, Onishi K, Utsunomiya M, Nakamura M. Our treatment strategy for critical limb ischemia. Int J Vasc Med 2013;2013:437471.
122. Toscano N, Holtzclaw D. Surgical considerations in the use of platelet-rich plasma. Compend Contin Educ Dent 2008;29:182–185.
123. Smith SE, Roukis TS. Bone and wound healing augmentation with platelet-rich plasma. Clin Podiatr Med Surg 2009;26:559–588.
124. Maney P, Amornporncharoen M, Palaiologou A. Applications of plasma rich in growth factors (PRGF) in dental surgery: A review. J West Soc Periodontol Periodontal Abstr 2013;61:99–104.
125. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spinal fusion. Bone 1999;25(2 suppl):47S–50S.
126. Jenis LG, Banco RJ, Kwon B. A prospective study of autologous growth factors (AGF) in lumbar interbody fusion. Spine J 2006;6:14–20.
127. Dimar JR 2nd, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am 2009;91:1377–1386.
128. Zhang H, Wang F, Ding L, et al. A meta-analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft. PLoS One 2014;9:e97049.
129. Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N. Distraction osteogenesis of the lower extremity in patients with achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma. J Pediatr Orthop 2007;27:629–634.
130. Kitoh H, Kawasumi M, Kaneko H, Ishiguro N. Differential effects of culture-expanded bone marrow cells on the regeneration of bone between the femoral and the tibial lengthenings. J Pediatr Orthop 2009;29:643–649.
131. Kim SJ, Pierce W, Sabharwal S. The etiology of short stature affects the clinical outcome of lower limb lengthening using external fixation. A systematic review of 18 trials involving 547 patients. Acta Orthop 2014;85:181–186.
132. Weibrich G, Kleis WK, Hitzler WE, Hafner G. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: A technical report. Int J Oral Maxillofac Implants 2005;20:118–123.
133. Gandhi A, Bibbo C, Pinzur M, Lin SS. The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin 2005;10:621–637.
134. Bibbo C, Hatfield PS. Platelet-rich plasma concentrate to augment bone fusion. Foot Ankle Clin 2010;15:641–649.
135. Bielecki T, Gazdzik TS, Szczepanski T. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res 2008;40:289–296.
136. Nathan ST, Fisher BE, Roberts CS, Giannoudis PV. The management of nonunion and delayed union of patella fractures: A systematic review of the literature. Int Orthop 2011;35:791–795.
137. Del Corso M, Vervelle A, Simonpieri A, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Curr Pharm Biotechnol 2012;13:1207–1230.
138. Simonpieri A, Del Corso M, Vervelle A, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol 2012;13:1231–1256.
139. Roffi A, Filardo G, Kon E, Marcacci M. Does PRP enhance bone integration with grafts, graft substitutes, or implants? A systematic review. BMC Musculoskelet Disord 2013;14:330.
140. Georgakopoulos I, Tsantis S, Georgakopoulos P, et al. The impact of platelet rich plasma (PRP) in osseointegration of oral implants in dental panoramic radiography: Texture based evaluation. Clin Cases Miner Bone Metab 2014;11:59–66.
141. Davis VL, Abukabda AB, Radio NM, et al. Platelet-rich preparations to improve healing. Part I: Workable options for every size practice. J Oral Implantol 2014;40:500–510.
142. Schwartz-Arad D, Ofec R, Eliyahu G, Ruban A, Sterer N. Long-term follow-up of dental implants placed in autologous onlay bone graft. Clin Implant Dent Relat Res 2016;18:449–461.
143. Ntounis A, Geurs N, Vassilopoulos P, Reddy M. Clinical assessment of bone quality of human extraction sockets after conversion with growth factors. Int J Oral Maxillofac Implants 2015;30:196–201.
144. Grant WP, Jerlin EA, Pietrzak WS, Tam HS. The utilization of autologous growth factors for the facilitation of fusion in complex neuropathic fractures in the diabetic population. Clin Podiatr Med Surg 2005;22:561–584.
145. Sood A, Cunningham C, Lin S. The BB Wistar rat as a diabetic model for fracture healing. ISRN Endocrinol 2013;2013:349604.
146. Chahla J, Cimque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasmapreparation protocols and composition reporting. A systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017;99:1769–1779.
147. Mautner K, Malanga GA, Smith J, et al. A call for a standard classification system for future biologic research: The rationale for new PRP nomenclature. Phys Med Rehabil 2015;7(4 suppl):S53–S59.
148. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27:158–167.
149. Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent 2001;10:225–228.
150. Rughetti A, Giusti I, D’Ascenzo S, et al. Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells. Blood Transfus 2008;6:12–17.
151. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: A review and author’s perspective. J Cutan Aesthet Surg 2014;7:189–197.
152. Anitua E, Aguirre JJ, Algorta J, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 2008;84:415–421.
153. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012;94:308–316.
154. Araki J, Jona M, Eto H, et al. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods 2012;18:176–185.
155. Bausset O, Giraudo L, Veran J, et al. Formulation and storage of platelet-rich plasma homemade product. Biores Open Access 2012;1:115–123.
156. Amable PR, Carias RB, Teixeira MV, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 2013;4:67.
157. Kececi Y, Ozsu S, Bilgir O. A cost-effective method for obtaining standard platelet-rich plasma. Wounds 2014;26:232–238.
158. Evanson JR, Guyton MK, Oliver DL, et al. Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. Mil Med 2014;179:799–805.
159. Bowlin GL, Sell SA. Platelet-rich plasma in bone regeneration: Engineering the delivery for improved clinical efficacy. Biomed Res Int 2014;2014:392398.
160. Han B, Woodell-May J, Ponticiello M, Yang Z, Nimni M. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am 2009;91:1459–1470.
